1. Home
  2. ALT vs RXT Comparison

ALT vs RXT Comparison

Compare ALT & RXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALT
  • RXT
  • Stock Information
  • Founded
  • ALT 1997
  • RXT 1998
  • Country
  • ALT United States
  • RXT United States
  • Employees
  • ALT N/A
  • RXT N/A
  • Industry
  • ALT Biotechnology: Pharmaceutical Preparations
  • RXT EDP Services
  • Sector
  • ALT Health Care
  • RXT Technology
  • Exchange
  • ALT Nasdaq
  • RXT Nasdaq
  • Market Cap
  • ALT 327.4M
  • RXT 280.1M
  • IPO Year
  • ALT N/A
  • RXT 2020
  • Fundamental
  • Price
  • ALT $3.57
  • RXT $1.44
  • Analyst Decision
  • ALT Strong Buy
  • RXT Hold
  • Analyst Count
  • ALT 6
  • RXT 5
  • Target Price
  • ALT $17.40
  • RXT $1.58
  • AVG Volume (30 Days)
  • ALT 2.3M
  • RXT 1.1M
  • Earning Date
  • ALT 11-11-2025
  • RXT 11-11-2025
  • Dividend Yield
  • ALT N/A
  • RXT N/A
  • EPS Growth
  • ALT N/A
  • RXT N/A
  • EPS
  • ALT N/A
  • RXT N/A
  • Revenue
  • ALT $20,000.00
  • RXT $2,693,100,000.00
  • Revenue This Year
  • ALT N/A
  • RXT N/A
  • Revenue Next Year
  • ALT $761,880.20
  • RXT $1.59
  • P/E Ratio
  • ALT N/A
  • RXT N/A
  • Revenue Growth
  • ALT N/A
  • RXT N/A
  • 52 Week Low
  • ALT $2.90
  • RXT $1.00
  • 52 Week High
  • ALT $11.16
  • RXT $3.41
  • Technical
  • Relative Strength Index (RSI)
  • ALT 44.06
  • RXT 56.67
  • Support Level
  • ALT $3.54
  • RXT $1.32
  • Resistance Level
  • ALT $3.72
  • RXT $1.52
  • Average True Range (ATR)
  • ALT 0.16
  • RXT 0.10
  • MACD
  • ALT 0.01
  • RXT 0.01
  • Stochastic Oscillator
  • ALT 10.94
  • RXT 73.33

About ALT Altimmune Inc.

Altimmune Inc is a clinical-stage biopharmaceutical company focused on developing treatments for obesity, metabolic diseases, and liver diseases. Its product candidate, pemvidutide (formerly known as ALT-801), is a novel, investigational, peptide-based GLP-1/glucagon dual receptor agonist. Pemvidutide is currently in clinical development for obesity and metabolic-associated steatohepatitis (MASH). The company also plans to pursue additional indications for pemvidutide that leverage the differentiated clinical profile of pemvidutide.

About RXT Rackspace Technology Inc.

Rackspace Technology Inc is an end-to-end, hybrid, multi cloud technology services company. It designs, builds and operates its customers' cloud environments across all technology platforms, irrespective of technology stack or deployment model. The company's solutions include Application Services; Data; Colocation; Cloud; Managed Hosting; Professional Services; and Security & Compliance. It operates in segments namely, Private Cloud, and Public Cloud. It generates revenue through the sale of consumption-based contracts for its service offerings and from the sale of professional services related to designing and building custom solutions.

Share on Social Networks: